Hedge Fund - 12 West Capital Management
Alnylam Pharmaceuticals Inc. (ALNY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2021 - Q1 (2021-03-31) | $0 | 0% | 0 | $150.49 |
| 2 | 2020 - Q4 (2020-12-31) | $95,528,000 | 4.1% | 735,000 | $133.53 |
| 3 | 2020 - Q3 (2020-09-30) | $107,016,000 | 5.2% | 735,000 | $142.11 |
| 4 | 2020 - Q2 (2020-06-30) | $108,861,000 | 5.62% | 735,000 | $134.81 |
| 5 | 2020 - Q1 (2020-03-31) | $80,005,000 | 4.76% | 735,000 | $115.43 |
| 6 | 2019 - Q4 (2019-12-31) | $84,650,000 | 5.33% | 735,000 | $99.70 |
| 7 | 2019 - Q3 (2019-09-30) | $59,109,000 | 3.8% | 735,000 | $79.11 |
| 8 | 2019 - Q2 (2019-06-30) | $53,332,000 | 4.01% | 735,000 | $76.72 |
| 9 | 2019 - Q1 (2019-03-31) | $68,686,000 | 5.6% | 735,000 | $83.64 |
| 10 | 2018 - Q4 (2018-12-31) | $53,589,000 | 5.51% | 735,000 | $76.92 |
| 11 | 2018 - Q3 (2018-09-30) | $64,327,000 | 4.72% | 735,000 | $100.59 |
| 12 | 2018 - Q2 (2018-06-30) | $72,390,000 | 5.96% | 735,000 | $99.19 |
| 13 | 2018 - Q1 (2018-03-31) | $83,370,000 | 9.16% | 700,000 | $128.92 |
| 14 | 2017 - Q4 (2017-12-31) | $88,935,000 | 10.75% | 700,000 | $125.65 |
| 15 | 2017 - Q3 (2017-09-30) | $82,243,000 | 11.5% | 700,000 | $85.36 |
| 16 | 2017 - Q2 (2017-06-30) | $55,832,000 | 9.44% | 700,000 | $63.91 |
| 17 | 2017 - Q1 (2017-03-31) | $35,875,000 | 7.13% | 700,000 | $46.22 |
| 18 | 2016 - Q4 (2016-12-31) | $26,208,000 | 4.65% | 700,000 | $41.87 |
| 19 | 2016 - Q3 (2016-09-30) | $47,446,000 | 6.8% | 700,000 | $70.55 |
| 20 | 2016 - Q2 (2016-06-30) | $38,843,000 | 6.26% | 700,000 | $63.00 |
| 21 | 2016 - Q1 (2016-03-31) | $43,688,000 | 6.07% | 696,000 | $66.49 |
| 22 | 2015 - Q4 (2015-12-31) | $61,285,000 | 8.74% | 651,000 | $92.72 |
| 23 | 2015 - Q3 (2015-09-30) | $52,314,000 | 7.63% | 651,000 | $111.10 |
| 24 | 2015 - Q2 (2015-06-30) | $78,035,000 | 8.91% | 651,000 | $119.50 |
| 25 | 2015 - Q1 (2015-03-31) | $67,977,000 | 7.56% | 651,000 | $101.34 |
| 26 | 2014 - Q4 (2014-12-31) | $63,147,000 | 7.83% | 651,000 | $92.65 |
| 27 | 2014 - Q3 (2014-09-30) | $50,843,000 | 5.93% | 651,000 | $64.51 |
The displayed share prices are average quarterly stock market prices.